Luminex and ELISA assays are optional endpoints for all of our in vivo and ex vivo research platforms. We have utilized these plate-based assays to evaluate samples (e.g., tumor and serum/plasma) from our well-characterized PDX tumor bank and can evaluate cell function, establish a mechanism of action, and determine pharmacodynamics.
These assays specifically evaluate secreted proteins and can be combined with our flow cytometry services when assessed in parallel with intracellular cytokines produced by specific cell types.
